title: Mutations in the DNA-binding domain of NR2E3 affect in vivo dimerization and interaction with CRX.
abstract: BACKGROUND
  NR2E3 (PNR) is an orphan nuclear receptor essential for proper photoreceptor determination and differentiation. In humans, mutations in NR2E3 have been associated with the recessively inherited enhanced short wavelength sensitive (S-) cone syndrome (ESCS) and, more recently, with autosomal dominant retinitis pigmentosa (adRP). NR2E3 acts as a suppressor of the cone generation program in late mitotic retinal progenitor cells. In adult rod photoreceptors, NR2E3 represses cone-specific gene expression and acts in concert with the transcription factors CRX and NRL to activate rod-specific genes. NR2E3 and CRX have been shown to physically interact in vitro through their respective DNA-binding domains (DBD). The DBD also contributes to homo- and heterodimerization of nuclear receptors.
  
  
  RESULTS
  We analyzed NR2E3 homodimerization and NR2E3/CRX complex formation in an in vivo situation by Bioluminescence Resonance Energy Transfer (BRET(2)). NR2E3 wild-type protein formed homodimers in transiently transfected HEK293T cells. NR2E3 homodimerization was impaired in presence of disease-causing mutations in the DBD, except for the p.R76Q and p.R104W mutant proteins. Strikingly, the adRP-linked p.G56R mutant protein interacted with CRX with a similar efficiency to that of NR2E3 wild-type and p.R311Q proteins. In contrast, all other NR2E3 DBD-mutant proteins did not interact with CRX. The p.G56R mutant protein was also more effective in abolishing the potentiation of rhodospin gene transactivation by the NR2E3 wild-type protein. In addition, the p.G56R mutant enhanced the transrepression of the M- and S-opsin promoter, while all other NR2E3 DBD-mutants did not.
  
  
  CONCLUSIONS
  These results suggest different disease mechanisms in adRP- and ESCS-patients carrying NR2E3 mutations. Titration of CRX by the p.G56R mutant protein acting as a repressor in trans may account for the severe clinical phenotype in adRP patients.
authors.affiliation: IRO, Institute for Research in Ophthalmology, Sion, Switzerland. raphael.roduit@irovision.ch
authors.forename: Raphael
authors.initials: R
authors.lastname: Roduit
authors.forename: Pascal
authors.initials: P
authors.lastname: Escher
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Schorderet
mesh_terms: D002460:Cell Line; D019281:Dimerization; D005786:Gene Expression Regulation; D049452:Green Fluorescent Proteins / Q000737:chemistry; D018398:Homeodomain Proteins / Q000737:chemistry*; D006801:Humans; D008938:Mitosis; D008958:Models, Molecular; D009154:Mutation; D057093:Orphan Nuclear Receptors / Q000737:chemistry*; D017434:Protein Structure, Tertiary; D012160:Retina / Q000166:cytology; D017948:Retinal Rod Photoreceptor Cells / Q000378:metabolism; D012174:Retinitis Pigmentosa / Q000378:metabolism; D013234:Stem Cells / Q000166:cytology; D015534:Trans-Activators / Q000737:chemistry*
chemical_list: D018398:Homeodomain Proteins; C403073:NR2E3 protein, human; D057093:Orphan Nuclear Receptors; D015534:Trans-Activators; C109288:cone rod homeobox protein; D049452:Green Fluorescent Proteins